Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer
MS Elizabeth, CG Christian - Mini Reviews in Medicinal …, 2024 - ingentaconnect.com
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks
estrogen and progesterone receptors and does not overexpress the human epidermal …
estrogen and progesterone receptors and does not overexpress the human epidermal …
Immunotherapy treatment for triple negative breast cancer
ER Berger, T Park, A Saridakis, M Golshan… - Pharmaceuticals, 2021 - mdpi.com
Triple-negative breast cancer (TNBC) is considered one of the highest-risk subtypes of
breast cancer and has dismal prognosis. Local recurrence rate after standard therapy in the …
breast cancer and has dismal prognosis. Local recurrence rate after standard therapy in the …
Combination immunotherapy strategies for triple-negative breast cancer: current progress and barriers within the pharmacological landscape
Introduction Triple-negative breast cancer (TNBC) is a breast cancer subtype characterized
by poorer prognosis. Despite that TNBC can display immunogenic features, anti-PD (L) 1 …
by poorer prognosis. Despite that TNBC can display immunogenic features, anti-PD (L) 1 …
Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer
E Agostinetto, A Losurdo, G Nader-Marta… - Expert opinion on …, 2022 - Taylor & Francis
Introduction Triple negative breast cancer (TNBC) is an area of high unmet medical need in
terms of new effective treatment strategies. Although breast cancer is traditionally …
terms of new effective treatment strategies. Although breast cancer is traditionally …
Immunotherapy in triple-negative breast cancer
LA Emens - The Cancer Journal, 2021 - journals.lww.com
Triple-negative breast cancer (TNBC) is an aggressive subtype of mammary carcinoma. A
subset of TNBC is immune activated, suggesting that immunotherapy may be a viable …
subset of TNBC is immune activated, suggesting that immunotherapy may be a viable …
Immunotherapy in triple-negative breast cancer
H Katz, M Alsharedi - Medical oncology, 2018 - Springer
Breast cancer can be classified based on the expression or lack of expression of protein
receptors including estrogen receptor (ER), progesterone receptor (PR) and human …
receptors including estrogen receptor (ER), progesterone receptor (PR) and human …
Hope and hype around immunotherapy in triple-negative breast cancer
F Jacobs, E Agostinetto, C Miggiano, R De Sanctis… - Cancers, 2023 - mdpi.com
Simple Summary Triple-negative breast cancer (TNBC) is the most aggressive breast cancer
subtype accounting for approximately 10–20% of all cases. Due to a lack of actionable …
subtype accounting for approximately 10–20% of all cases. Due to a lack of actionable …
Immunotherapeutic Approaches in Triple‐Negative Breast Cancer: State of the Art and Future Perspectives
K Oualla, L Kassem, L Nouiakh… - … journal of breast …, 2020 - Wiley Online Library
Triple‐negative breast cancer (TNBC) is characterized by the absence of estrogen receptor
(ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It …
(ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It …
Novel approaches to immunotherapy in triple negative breast cancer
S Tabarestani, M Esmaeil-Akbari… - International Journal of …, 2018 - brieflands.com
Context: Triple negative breast cancers (TNBC) constitute about 15% of breast neoplasms.
In contrast to estrogen receptor (ER) or human epidermal growth factor receptor (HER2) …
In contrast to estrogen receptor (ER) or human epidermal growth factor receptor (HER2) …
Immunotherapy for triple-negative breast cancer: combination strategies to improve outcome
L Li, F Zhang, Z Liu, Z Fan - Cancers, 2023 - mdpi.com
Simple Summary For decades, countless efforts have been devoted to developing targeted
drugs to improve the prognosis of triple-negative breast cancer (TNBC). Among the novel …
drugs to improve the prognosis of triple-negative breast cancer (TNBC). Among the novel …
相关搜索
- breast cancer immunotherapy in combination
- breast cancer checkpoint inhibitors
- breast cancer immunotherapeutic approaches
- breast cancer hope and hype
- breast cancer pharmacological landscape
- breast cancer combination with chemotherapy
- breast cancer immunotherapy treatment
- breast cancer use of immunotherapy
- breast cancer immunotherapy for patients
- breast cancer combination strategies